Stevens Capital Management LP Dexcom Inc Transaction History

Stevens Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $273,527 - $318,543	2,432 Added 71.74%	5,822 $748,000
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $352,560 - $416,698	3,390 New	3,390 $394,000
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $184,490 - $255,322	-1,961 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$129.87 - $162.82 $254,675 - $319,290	1,961 New	1,961 $1.05 Million
Q2 2021 Aug 12, 2021	SELL	$80.99 - $107.93 $123,509 - $164,593	-1,525 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$84.79 - $104.74 $129,304 - $159,728	1,525 New	1,525 $548,000
Q2 2019 Jul 31, 2019	SELL	$27.84 - $38.92 $883,975 - $1.24 Million	-31,752 Closed	0 $0
Q1 2019 May 03, 2019	SELL	$28.07 - $38.18 $224,868 - $305,859	-8,011 Reduced 20.15%	31,752 $3.78 Million
Q4 2018 Feb 06, 2019	BUY	$26.99 - $37.37 $337,078 - $466,713	12,489 Added 45.79%	39,763 $4.76 Million
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $636,847 - $1 Million	27,274 New	27,274 $3.9 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.